Chris Tikellis

Summary

Country: Australia

Publications

  1. ncbi Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease
    Chris Tikellis
    Division of Diabetic Complications, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
    Curr Opin Nephrol Hypertens 20:62-8. 2011
  2. ncbi Direct antiatherosclerotic effects of PPAR agonists
    Karin A M Jandeleit-Dahm
    Diabetes Division, Albert Einstein JDRF Centre for Diabetes Complications, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
    Curr Opin Lipidol 20:24-9. 2009
  3. ncbi Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes
    Chris Tikellis
    Baker IDI Heart and Diabetes Institute, PO Box 6492, Melbourne, Australia
    Clin Sci (Lond) 124:617-26. 2013
  4. ncbi Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes
    Chris Tikellis
    Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Central, Melbourne 8008, Australia
    Clin Sci (Lond) 123:519-29. 2012

Detail Information

Publications4

  1. ncbi Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease
    Chris Tikellis
    Division of Diabetic Complications, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
    Curr Opin Nephrol Hypertens 20:62-8. 2011
    ..Angiotensin-converting enzyme 2 (ACE2) has recently emerged as a key regulator of the renin-angiotensin system in both health and disease...
  2. ncbi Direct antiatherosclerotic effects of PPAR agonists
    Karin A M Jandeleit-Dahm
    Diabetes Division, Albert Einstein JDRF Centre for Diabetes Complications, Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia
    Curr Opin Lipidol 20:24-9. 2009
    ..The purpose of this review is to evaluate the currently available evidence for a direct vasculoprotective effect of PPAR agonists...
  3. ncbi Association of dietary sodium intake with atherogenesis in experimental diabetes and with cardiovascular disease in patients with Type 1 diabetes
    Chris Tikellis
    Baker IDI Heart and Diabetes Institute, PO Box 6492, Melbourne, Australia
    Clin Sci (Lond) 124:617-26. 2013
    ....
  4. ncbi Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes
    Chris Tikellis
    Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Central, Melbourne 8008, Australia
    Clin Sci (Lond) 123:519-29. 2012
    ....